Frank Pasqualone

Frank Pasqualone

Director/Board Member at ENVERIC BIOSCIENCES, INC.

Net worth: 10 908 $ as of 2026-06-29

70 year
Health Technology
Consumer Services
Health Services

Profile

Frank C.
Pasqualone
is currently an Independent Director at Enveric Biosciences, Inc. since 2022 and a Trustee at Saint Francis University since 2018.
Former roles include Director at Prevent Cancer Foundation, President-Intercontinental Region at Bristol Myers Squibb Co. from 2010 to 2012, Senior Vice President-Operations at Innoviva, Inc., and Chief Commercial Operations Officer & Senior VP at Theravance Biopharma, Inc. Education includes an undergraduate degree from Bowling Green State University and an MBA from the University of Dayton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 7,904 ( 0.21% ) 10 908 $ 2026-06-29

Frank Pasqualone active positions

CompaniesPositionStart
ENVERIC BIOSCIENCES, INC. Director/Board Member 2022-07-12
Director/Board Member 2018-09-30

Former positions of Frank Pasqualone

CompaniesPositionEnd
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 2011-12-31
INNOVIVA, INC. Chief Operating Officer -
THERAVANCE BIOPHARMA, INC. Chief Operating Officer -
Director/Board Member -
See the detail of Frank Pasqualone's experience

Training of Frank Pasqualone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

36

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Frank Pasqualone